Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Dianna Quan

Concepts (162)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Polyneuropathies
7
2022
50
1.920
Why?
Muscular Atrophy, Spinal
2
2021
17
1.310
Why?
Amyloid Neuropathies, Familial
3
2022
8
1.220
Why?
Motor Neuron Disease
2
2021
16
0.850
Why?
Amyotrophic Lateral Sclerosis
2
2021
61
0.810
Why?
Neural Conduction
4
2018
79
0.790
Why?
Point Mutation
2
2016
217
0.710
Why?
Muscle, Skeletal
3
2019
1472
0.700
Why?
Muscle Weakness
4
2018
80
0.660
Why?
Myositis
1
2019
44
0.630
Why?
Prealbumin
3
2022
22
0.600
Why?
Neuromuscular Diseases
2
2008
89
0.570
Why?
Electromyography
5
2021
326
0.570
Why?
TRPV Cation Channels
1
2016
28
0.540
Why?
Critical Illness
3
2018
643
0.520
Why?
Biopsy
1
2019
1045
0.500
Why?
Polymyositis
1
2011
15
0.380
Why?
Muscular Dystrophies
1
2011
36
0.370
Why?
Pain
1
2016
710
0.370
Why?
Multiple Sclerosis
2
2005
380
0.360
Why?
Intensive Care Units
6
2018
619
0.350
Why?
Electrodiagnosis
2
2012
15
0.340
Why?
Receptors, Cholinergic
1
2008
41
0.320
Why?
Nervous System Diseases
1
2011
252
0.300
Why?
Diagnostic Errors
1
2008
151
0.290
Why?
Patient Discharge
3
2018
769
0.280
Why?
Diagnosis, Differential
4
2016
1355
0.280
Why?
Antibodies
1
2008
372
0.270
Why?
Neuralgia, Postherpetic
1
2006
44
0.260
Why?
Valine
1
2006
72
0.260
Why?
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
1
2005
4
0.260
Why?
Acyclovir
1
2006
100
0.260
Why?
Spinal Nerve Roots
1
2005
28
0.250
Why?
Cranial Nerve Diseases
1
2005
42
0.250
Why?
Neuralgia
2
2021
122
0.230
Why?
Peripheral Nervous System Diseases
1
2005
121
0.230
Why?
Myasthenia Gravis
1
2023
18
0.220
Why?
Activities of Daily Living
2
2023
350
0.210
Why?
Ketamine
1
2003
92
0.200
Why?
Humans
25
2023
114937
0.200
Why?
Nortriptyline
1
2021
5
0.190
Why?
Duloxetine Hydrochloride
1
2021
8
0.190
Why?
Aged
10
2021
19122
0.180
Why?
Antiviral Agents
1
2006
647
0.180
Why?
Sural Nerve
2
2014
19
0.180
Why?
Analgesics
1
2021
158
0.160
Why?
Motor Neurons
1
2021
212
0.160
Why?
Herpes Zoster
1
2003
333
0.160
Why?
RNA, Small Interfering
1
2020
543
0.160
Why?
Adult
10
2021
30608
0.150
Why?
Female
16
2021
59581
0.150
Why?
Middle Aged
11
2021
26806
0.150
Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
243
0.150
Why?
Pain Management
1
2021
289
0.150
Why?
Male
15
2021
55663
0.150
Why?
Rhabdomyolysis
1
2015
16
0.130
Why?
Aged, 80 and over
3
2019
6364
0.120
Why?
Patient Outcome Assessment
1
2016
122
0.120
Why?
Treatment Outcome
3
2022
9105
0.120
Why?
Sensitivity and Specificity
1
2019
1700
0.120
Why?
Prospective Studies
4
2018
6218
0.120
Why?
Physical Exertion
1
2015
211
0.120
Why?
Peroneal Nerve
1
2014
19
0.120
Why?
Neurologic Examination
1
2014
114
0.110
Why?
Muscle Strength
1
2016
270
0.110
Why?
Electrophysiology
1
2014
201
0.110
Why?
Muscular Diseases
2
2017
105
0.110
Why?
Quality of Life
2
2022
2359
0.110
Why?
Biomarkers
1
2022
3418
0.100
Why?
Bed Rest
1
2012
15
0.100
Why?
Immunoglobulins
2
2009
143
0.100
Why?
Phenotype
2
2016
2817
0.090
Why?
Antibodies, Monoclonal
2
2023
1270
0.090
Why?
Physical Examination
1
2011
220
0.080
Why?
Meningoencephalitis
1
2009
24
0.080
Why?
Retrospective Studies
3
2019
12544
0.080
Why?
Physical Therapy Modalities
1
2012
264
0.080
Why?
West Nile Fever
1
2009
50
0.080
Why?
Frontal Lobe
1
2010
140
0.080
Why?
Respiration, Artificial
3
2018
526
0.080
Why?
Electrodes
1
2008
100
0.080
Why?
Sepsis
1
2014
508
0.080
Why?
Psychiatric Status Rating Scales
1
2010
483
0.070
Why?
Immunocompromised Host
1
2009
196
0.070
Why?
Immunologic Factors
1
2009
221
0.070
Why?
Lung Transplantation
1
2009
246
0.070
Why?
Glycogen Storage Disease Type IIb
1
2007
22
0.070
Why?
Young Adult
2
2019
10478
0.070
Why?
Injections, Intravenous
1
2006
201
0.070
Why?
Peripheral Nervous System
1
2005
17
0.060
Why?
Action Potentials
1
2008
406
0.060
Why?
Cognition Disorders
1
2010
476
0.060
Why?
Neuropsychological Tests
1
2010
913
0.060
Why?
Guillain-Barre Syndrome
1
2005
21
0.060
Why?
Cranial Nerves
1
2005
11
0.060
Why?
Executive Function
1
2010
376
0.060
Why?
Nerve Fibers, Myelinated
1
2005
41
0.060
Why?
Adolescent
3
2019
17829
0.060
Why?
Exercise
1
2015
1643
0.060
Why?
Graves Disease
1
2005
32
0.060
Why?
Hypertrophy
1
2005
111
0.060
Why?
Nerve Tissue Proteins
1
2008
529
0.060
Why?
Friedreich Ataxia
1
2005
64
0.060
Why?
Evidence-Based Medicine
1
2008
675
0.060
Why?
Treatment Failure
1
2005
332
0.060
Why?
Administration, Oral
1
2006
731
0.060
Why?
Cardiomyopathy, Dilated
1
2007
346
0.060
Why?
Myelin Sheath
1
2005
144
0.060
Why?
Central Nervous System
1
2005
238
0.060
Why?
Axons
1
2005
177
0.060
Why?
Drug Evaluation
1
2003
77
0.050
Why?
Drug Therapy, Combination
1
2006
954
0.050
Why?
Administration, Cutaneous
1
2003
117
0.050
Why?
Gels
1
2003
72
0.050
Why?
Carpal Tunnel Syndrome
1
2002
27
0.050
Why?
Patients
1
2023
162
0.050
Why?
North America
1
2002
257
0.050
Why?
Analgesics, Non-Narcotic
1
2003
117
0.050
Why?
Pregabalin
1
2021
9
0.050
Why?
Immunosuppressive Agents
1
2005
648
0.050
Why?
Mexiletine
1
2021
7
0.050
Why?
Comparative Effectiveness Research
1
2021
130
0.040
Why?
Infusions, Intravenous
1
2020
372
0.040
Why?
Bayes Theorem
1
2021
331
0.040
Why?
Severity of Illness Index
2
2020
2542
0.040
Why?
Hospital Charges
1
2017
38
0.040
Why?
Propensity Score
1
2017
224
0.030
Why?
APACHE
1
2016
58
0.030
Why?
Electrophysiological Phenomena
1
2016
48
0.030
Why?
Autoantibodies
1
2023
1354
0.030
Why?
Creatine Kinase
1
2015
75
0.030
Why?
Ultrasonography
1
2018
633
0.030
Why?
Magnetic Resonance Imaging
1
2005
3053
0.030
Why?
Brain
1
2005
2372
0.030
Why?
Hospital Mortality
1
2017
776
0.030
Why?
Length of Stay
1
2017
949
0.030
Why?
Logistic Models
1
2017
1844
0.030
Why?
Patient Readmission
1
2017
608
0.030
Why?
Respiratory Muscles
1
2012
28
0.020
Why?
Mobility Limitation
1
2012
60
0.020
Why?
Predictive Value of Tests
1
2016
1801
0.020
Why?
Muscular Atrophy
1
2012
78
0.020
Why?
Muscle Fatigue
1
2012
94
0.020
Why?
Disability Evaluation
1
2012
271
0.020
Why?
Child
1
2008
18366
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2009
82
0.020
Why?
Colorado
1
2018
4091
0.020
Why?
Cohort Studies
1
2018
4903
0.020
Why?
Fatal Outcome
1
2009
285
0.020
Why?
alpha 1-Antitrypsin Deficiency
1
2009
76
0.020
Why?
Rituximab
1
2009
151
0.020
Why?
Time Factors
1
2017
6125
0.020
Why?
Lysosomal-Associated Membrane Protein 2
1
2007
26
0.020
Why?
Graft Rejection
1
2009
516
0.020
Why?
Pedigree
1
2007
467
0.020
Why?
Pilot Projects
1
2010
1372
0.020
Why?
Algorithms
1
2012
1474
0.010
Why?
B-Lymphocytes
1
2009
772
0.010
Why?
Prognosis
1
2012
3344
0.010
Why?
Disease Progression
1
2009
2392
0.010
Why?
Mutation
1
2007
3354
0.010
Why?
Infant
1
2007
7937
0.010
Why?
Quan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)